Gainesville, FL, United States of America

Sergei Zolotukhin

This inventor holds 38 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 4 EPO patents, primarily in AAV Gene Therapy. Top assignees: University of Florida Research Foundation Inc., The State University of New York, The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 1997-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergei Zolotukhin. Retrieved from https://idiyas.com/inventor/sergei-zolotukhin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 12)

% Patents Active = 94.7

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 3.3

ph-index = 17

Forward Citations = 1,137(Granted Patents)

Company Filing History:

32 out of 3,056

University of Florida Research Foundation Inc.

patents

4 out of 2,046

The State University of New York

patents

3 out of 641

The UAB Research Foundation (The University of Alabama at Birmingham)

patents

4. 1 out of 6

Applied Genetic Technologies Corporation

patents

5. 1 out of 3,697

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 1997-2026

Loading Chart...

Areas of Expertise:

AAV Capsid Variants

Gene Therapy

Transduction Efficiency

Satiation Peptides

Recombinant AAV

Baculovirus System

Tyrosine-Modified Vectors

Synthetic Combinatorial Library

Human Liver Cancer

Glioblastoma Cells

Pseudotyped AAV Virions

Green Fluorescent Protein

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12644132 - NOVEL AAV3B VARIANTS THAT TARGET HEPATOCYTES AND EVADE THE HUMORAL IMMUNE RESPONSE (2026-06-02),

2. 12630845 - AAV capsid variants for targeting human glioblastoma cells (2026-05-19),

3. 12570699 - CAPSID-MODIFIED, RAAV3 VECTOR COMPOSITIONS AND METHODS OF USE IN GENE THERAPY OF HUMAN LIVER CANCER (2026-03-10),

4. 12358954 - Capsid-modified rAAV vector compositions and methods therefor (2025-07-15),

5. 12188037 - Synthetic combinatorial AAV3 capsid library (2025-01-07),

6. 12109251 - Satiation peptide administration (2024-10-08),

7. 11767346 - Modified AAV capsid proteins and uses thereof (2023-09-26),

8. 11702673 - Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus (2023-07-18),

9. 11384364 - Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus (2022-07-12),

10. 11332502 - Modified AAV capsid proteins and uses thereof (2022-05-17),

11. 11311633 - Satiation peptides for weight loss and altered taste sensitivity (2022-04-26),

12. 11103556 - Satiation peptide administration (2021-08-31),

13. 11091777 - Synthetic combinatorial AAV capsid library for targeted gene therapy (2021-08-17),

14. 10934327 - Capsid-modified, RAAV3 vector compositions and uses in gene therapy of human liver cancer (2021-03-02),

15. 10815279 - Capsid-modified rAAV vector compositions and methods therefor (2020-10-27),

Title: Sergei Zolotukhin: Pioneering Inventor from Gainesville

Introduction: Sergei Zolotukhin is a renowned inventor based in Gainesville, FL, known for his groundbreaking contributions to various technological fields.

Latest Patents: Sergei Zolotukhin holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Sergei Zolotukhin has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized their respective industries.

Collaborations: Throughout his career, Sergei Zolotukhin has collaborated with top universities, research institutions, and innovative companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Sergei Zolotukhin's passion for innovation and his relentless drive to push the boundaries of technology make him a true visionary in the world of inventions.

Profile summary based on public USPTO records.